Penicillamine/trientineBirth defects following in-utero exposure: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1728卷 / 1期

关键词：

D O I：

10.1007/s40278-018-54557-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：294 / 294

相关论文

共 50 条

[1] OfloxacinBirth defects following in-utero exposure: 2 case reports
Reactions Weekly, 2018, 1719 (1) : 173 - 173
[2] DolutegravirNeural tube defects following in-utero exposure: 6 case reports
Reactions Weekly, 2020, 1833 (1) : 162 - 162
[3] PropylthiouracilCongenital anomalies following in-utero exposure: 5 case reports
Reactions Weekly, 2017, 1678 (1) : 151 - 151
[4] Multiple drugsVarious toxicities following in-utero exposure: 5 case reports
Reactions Weekly, 2024, 2032 (1) : 336 - 336
[5] AntineoplasticsTeratogenicity following in-utero exposure: 4 case reports
Reactions Weekly, 2017, 1672 (1) : 39 - 39
[6] WarfarinEmbryopathy following in-utero exposure: 2 case reports
Reactions Weekly, 2019, 1752 (1) : 387 - 387
[7] MethotrexateCraniosynostosis following an in-utero exposure: 4 case reports
Reactions Weekly, 2017, 1633 (1) : 479 - 479
[8] Darunavir/raltegravir/ritonavirVarious birth defects following in-utero exposure: 11 case reports
Reactions Weekly, 2021, 1857 (1) : 127 - 127
[9] IsotretinoinRetinoic acid embryopathy following in-utero exposure of isotretinoin: 5 case reports
Reactions Weekly, 2025, 2045 (1) : 207 - 207
[10] IodineFetal goitre following in-utero exposure: 3 case reports
Reactions Weekly, 2021, 1885 (1) : 276 - 276

← 1 2 3 4 5 →